Growth Metrics

Palisade Bio (PALI) EBIT Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 32.96%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -29.67%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -50.81%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.47%
7 Evaxion A 62.56 Bn 62.54 Bn - 16.35%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -12.10%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 55.96%
10 Palisade Bio 439.25 Mn 309.68 Mn - -61.98%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -61.98%
Dec 31, 2025 -37.40%
Sep 30, 2025 12.84%
Jun 30, 2025 7.33%
Mar 31, 2025 15.93%
Dec 31, 2024 5.65%
Sep 30, 2024 -6.01%
Jun 30, 2024 49.58%
Mar 31, 2024 -23.41%
Dec 31, 2023 0.94%
Sep 30, 2023 -27.66%
Jun 30, 2023 -25.15%
Mar 31, 2023 -8.31%
Dec 31, 2022 -21.74%
Sep 30, 2022 -27.60%
Jun 30, 2022 -23.02%
Mar 31, 2022 -16.54%
Dec 31, 2021 -30.67%
Sep 30, 2021 -13.14%
Jun 30, 2021 -153.25%
Mar 31, 2021 5.95%
Dec 31, 2020 -12.67%
Sep 30, 2020 11.14%
Jun 30, 2020 24.15%
Mar 31, 2020 22.23%
Dec 31, 2019 27.74%
Sep 30, 2019 24.40%
Jun 30, 2019 20.61%
Mar 31, 2019 26.68%
Dec 31, 2018 25.42%
Sep 30, 2018 26.28%
Jun 30, 2018 26.01%
Mar 31, 2018 20.15%
Dec 31, 2017 21.22%
Sep 30, 2017 14.27%
Jun 30, 2017 -6.31%
Mar 31, 2017 6.50%
Dec 31, 2016 -26.95%
Sep 30, 2016 -10.60%
Jun 30, 2016 -5.82%
Mar 31, 2016 -29.18%
Dec 31, 2015 -16.86%
Sep 30, 2015 -26.25%
Jun 30, 2015 -27.97%
Mar 31, 2015 -23.26%
Dec 31, 2014 -21.90%
Sep 30, 2014 -8.41%
Jun 30, 2014 1.45%
Mar 31, 2014 -13.54%
Dec 31, 2013 7.13%
Sep 30, 2013 2.52%
Jun 30, 2013 8.29%